a public good project by the
Synthesis
Company
of California

© 2026

Catherine Vilchèze | doi.page

0 works0 citations0 h-index

Catherine Vilchèze

Albert Einstein College of Medicine(US)Montefiore Medical Center(US)

Publications by Year

Research Areas

Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Antibiotic Resistance in Bacteria, Cancer therapeutics and mechanisms, Biochemical and Molecular Research

Most-Cited Works

→ Effect of the Structure of Natural Sterols and Sphingolipids on the Formation of Ordered Sphingolipid/Sterol Domains (Rafts)(2001)527 cited
→ Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis(1995)368 cited
→ Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction(2013)329 cited
→ The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics(2007)328 cited
→ Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis(2015)327 cited
→ Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid(2006)323 cited

→ The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites(2008)

315 cited

→ Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD+ and a C16 Fatty Acyl Substrate(1999)288 cited

→ Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria(2005)281 cited

→ Inactivation of the inhA -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis(2000)278 cited